1,4-Dideoxy-1,4-imino-N-(4-guanidinobenzyl)-D-ribitol

ID: ALA505234

Chembl Id: CHEMBL505234

PubChem CID: 24813268

Max Phase: Preclinical

Molecular Formula: C13H20N4O3

Molecular Weight: 280.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)Nc1ccc(CN2C[C@H](O)[C@H](O)[C@H]2CO)cc1

Standard InChI:  InChI=1S/C13H20N4O3/c14-13(15)16-9-3-1-8(2-4-9)5-17-6-11(19)12(20)10(17)7-18/h1-4,10-12,18-20H,5-7H2,(H4,14,15,16)/t10-,11+,12-/m1/s1

Standard InChI Key:  ZQFHFKSXRFPQQC-GRYCIOLGSA-N

Alternative Forms

Associated Targets(non-human)

IAG-nucleoside hydrolase (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 280.33Molecular Weight (Monoisotopic): 280.1535AlogP: -1.11#Rotatable Bonds: 4
Polar Surface Area: 125.83Molecular Species: BASEHBA: 5HBD: 6
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.31CX Basic pKa: 10.11CX LogP: -1.17CX LogD: -4.08
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.31Np Likeness Score: 0.38

References

1. Goeminne A, McNaughton M, Bal G, Surpateanu G, Van Der Veken P, De Prol S, Versées W, Steyaert J, Haemers A, Augustyns K..  (2008)  Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.,  43  (2): [PMID:17582660] [10.1016/j.ejmech.2007.03.027]
2. Berg M, Kohl L, Van der Veken P, Joossens J, Al-Salabi MI, Castagna V, Giannese F, Cos P, Versées W, Steyaert J, Grellier P, Haemers A, Degano M, Maes L, de Koning HP, Augustyns K..  (2010)  Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis.,  54  (5): [PMID:20194690] [10.1128/aac.01787-09]

Source